Register to view the archived recording here.
PacBio Outlines Expected Commercial Performance for RS at AGBT as Users Talk About their Experience
At a conference workshop, PacBio reported on the performance of its system in seven early-access customer labs and said how it expects the instrument to perform at commercial launch in the second quarter.
New to GenomeWeb? Register here quickly.